Biomimetic Innovations Enters Agreement with Sanara MedTech

Biomimetic Innovations Enters Agreement with Sanara MedTech

Biomimetic Innovations (BMI) executed an exclusive license and distribution agreement with Sanara MedTech. In tandem, Sanara agreed to make a minority investment in cash for equity in BMI.

Sanara acquired exclusive U.S. marketing, sales, and distribution rights to OsStic Synthetic Injectable Structural Bio-Adhesive Bone Void Filler and a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0